I note that many of the larger ASX regenerative medicine stocks are dual listed in the USA. It appears that Orthocell also have a code on the OTC. Does anyone know if this is something new? It appears that no stock has traded under that OTC code as yet so perhaps something is in the pipeline for a dual listing here too?
ORHHF is the code
https://www.thestreet.com/quote/ORHHF.html
https://www.bloomberg.com/quote/ORHHF:US
US Listing
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.0¢ |
Change
-0.010(1.61%) |
Mkt cap ! $145.8M | |||
| Open | High | Low | Value | Volume |
| 62.5¢ | 63.0¢ | 61.0¢ | $1.181M | 1.913M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5445 | 61.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |